(9-365) Safety and Effectiveness of Transition from Intravenous to Subcutaneous Insulin on Post-Operative Day One in Patients Undergoing Coronary Artery Bypass Graft (CABG)

Wednesday, December 7, 2022

8:30 AM – 9:30 AM

Location: Bayside A, Level 1

Category: Research-in-Progress
Topic: Operating Room Pharmacy

Co-Author(s): Joel Weimer

Primary Author(s)

Abigail Antigua, PharmD
Advanced Clinical Pharmacist, Critical Care
HCA Florida North Florida Hospital, Florida